Massachusetts General Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT05543265
Chronic health conditions affect most older adults. Preventative medicine and risk management strategies, especially when applied earlier in life, are essential to altering the trajectory of a disease and ultimately improving health outcomes. Primary care providers (PCP) often provide most of these services, though younger adults are the least likely to receive primary care. This project leverages a period of high engagement and health activation during an individual's life (pregnancy) to nudge her toward use of primary care after the pregnancy episode. This randomized controlled trial will test the hypothesis that a behavioral science-informed intervention, incorporating defaults and salience, can increase the rates of PCP follow-up within 4 months following a delivery for individual with hypertension, diabetes, obesity. If successful, this intervention could serve as a scalable solution to increase primary care use and preventative health services in a population that currently has low rates of engagement and utilization of these services.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Individuals will be randomized with equal probability into either a treatment or control arm. The intervention combines several features designed to target reasons for low take-up of primary care among postpartum individuals. This project will leverage the potential value of defaults/opt-out, salient information, and reminders to encourage use of primary care. Individuals in both the intervention and control arms will receive information via the study institution's patient portal toward the end of the pregnancy regarding the importance and benefits of primary care in the postpartum year. This information will be similar to, but reinforcing, the information they would receive from their obstetrician about following up with their primary care physician. In addition to this initial message, individuals in the treatment arm will receive the following intervention components, developed based on recent evidence regarding behavioral science approaches to activating health behaviors:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Default primary care appointment scheduling
Patient-specific messages about the importance of postpartum care transition
Primary care appointment reminders
Time frame: 4 months after the patient's estimated date of delivery
Any visit with 1) a primary care provider (e.g., internal medicine, family medicine, pediatrics, gynecology) and 2) receipt of "annual" or "health care maintenance" services OR disease-specific management (diabetes, hypertension, obesity, mental health)
Time frame: 12 months after the patient's estimated date of delivery
Any visit with 1) a primary care provider (e.g., internal medicine, family medicine, pediatrics, gynecology) and 2) receipt of "annual" or "health care maintenance" services OR disease-specific management (diabetes, hypertension, obesity, mental health)
Time frame: 4 months after the patient's estimated date of delivery
Health care maintenance visit appointment with the patient's assigned primary care provider
Time frame: 12 months after the patient's estimated date of delivery
Health care maintenance visit appointment with the patient's assigned primary care provider
Time frame: 4 months after the patient's estimated date of delivery
Any visit to a urgent care or emergency room visit
Time frame: 12 months after the patient's estimated date of delivery
Any visit to a urgent care or emergency room visit
Time frame: 4 months after the patient's estimated date of delivery
Contraception plan documented by any provider after delivery
Time frame: 4 months after the patient's estimated date of delivery
Long-acting contraception use (implant, intrauterine device)
Time frame: 12 months after the patient's estimated date of delivery
Long-acting contraception use (implant, intrauterine device)
Time frame: 12 months after the patient's estimated date of delivery
Contraception plan documented by any provider after delivery
Time frame: 4 months after the patient's estimated date of delivery
Postpartum diabetes screening among those diagnosed with gestational diabetes
Time frame: 12 months after the patient's estimated date of delivery
Postpartum diabetes screening among those diagnosed with gestational diabetes
Time frame: 4 months after the patient's estimated date of delivery
Weight counseling documentation among those with obesity
Time frame: 12 months after the patient's estimated date of delivery
Weight counseling documentation among those with obesity
Time frame: 4 months after the patient's estimated date of delivery
Blood pressure documented in the EHR among those diagnosed within chronic or pregnancy-related hypertension
Time frame: 12 months after the patient's estimated date of delivery
Blood pressure documented in the EHR among those diagnosed within chronic or pregnancy-related hypertension
Time frame: 4 months after the patient's estimated date of delivery
Clinical support services (e.g., social work, psychiatry, therapy) for individuals with mood or anxiety disorders
Time frame: 12 months after the patient's estimated date of delivery
Clinical support services (e.g., social work, psychiatry, therapy) for individuals with mood or anxiety disorders
Time frame: 4 months after the patient's estimated date of delivery
New or continued antidepressant prescription use
Time frame: 12 months after the patient's estimated date of delivery
New or continued antidepressant prescription use
Time frame: 4 months after the patient's estimated date of delivery
New or continued antihypertensive medication use among individuals with hypertension
Time frame: 12 months after the patient's estimated date of delivery
New or continued antihypertensive medication use among individuals with hypertension
Time frame: 4 months after the patient's estimated date of delivery
New or continued oral or subcutaneous diabetes medication use control among individuals with diabetes
Time frame: 12 months after the patient's estimated date of delivery
New or continued oral or subcutaneous diabetes medication use control among individuals with diabetes
Time frame: 4 months after the patient's estimated date of delivery
Laboratory glucose screening test among individuals with or at risk for diabetes
Time frame: 12 months after the patient's estimated date of delivery
Laboratory glucose screening test among individuals with or at risk for diabetes
Time frame: 4 months after the patient's estimated date of delivery
Primary care provider visit attendance per patient report
Time frame: 12 months after the patient's estimated date of delivery
Primary care provider visit attendance per patient report
Massachusetts General Hospital
Other
Bridging the Gap From Postpartum to Primary Care: A Behavioral Science Informed Intervention to Improve Chronic Disease Management Among Postpartum Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01050465
Acne Vulgaris, Acneiform Eruptions
View Trial DetailsNCT00634608
Allergic Rhinitis, Anxiety
Columbia, Missouri, United States
View Trial DetailsNCT05144737
Body Weight, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT05541458
Body Weight, Cardiovascular Diseases
Helena, Texas, United States
View Trial Details